GlassScriptPhysician profile
Jennifer Tsai
NPI 1134532492
$274,756.47
in general payments reported to CMS, 2019-2025
18 companies · $42K in 2025
The $42K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,222 · 2020: $10K · 2021: $39K · 2022: $56K · 2023: $27K · 2024: $99K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $98K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Food and Beverage: $15K · Travel and Lodging: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,875 · Entertainment: $18.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $98,451.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,875.00 |
| Food and Beverage | $15,223.79 |
| Travel and Lodging | $12,058.81 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,875.00 |
| Entertainment | $18.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $78,078.91 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $61,680.18 | 2022-2024 | Biotrue, Infuse, Miebo |
| Lumenis Be INC | $43,988.40 | 2022-2023 | Optilight |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39,580.46 | 2020-2021 | |
| Alcon Vision LLC | $28,610.59 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Biotissue Holdings INC. | $11,036.29 | 2021-2025 | |
| Coopervision INC. | $6,052.85 | 2021-2023 | Ortho-K Contact Lens |
| Lumenis, INC | $3,354.75 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $889.26 | 2019-2024 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $386.50 | 2024-2025 | Xdemvy |
| Optos, INC. | $248.41 | 2019-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $236.10 | 2022-2025 | Oxervate |
| Oyster Point Pharma, INC. | $167.03 | 2022 | |
| Abbvie INC. | $163.05 | 2022-2023 | Lumigan, Vuity |
| Allergan, INC. | $130.54 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $70.60 | 2024 | Radius |
| Valley Contax, INC. | $60.00 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.